MX2021001272A - Composiciones de bismuto-tiol y metodos de uso. - Google Patents
Composiciones de bismuto-tiol y metodos de uso.Info
- Publication number
- MX2021001272A MX2021001272A MX2021001272A MX2021001272A MX2021001272A MX 2021001272 A MX2021001272 A MX 2021001272A MX 2021001272 A MX2021001272 A MX 2021001272A MX 2021001272 A MX2021001272 A MX 2021001272A MX 2021001272 A MX2021001272 A MX 2021001272A
- Authority
- MX
- Mexico
- Prior art keywords
- bismuth
- methods
- thiol
- thiol compositions
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862712563P | 2018-07-31 | 2018-07-31 | |
| US201962800925P | 2019-02-04 | 2019-02-04 | |
| PCT/US2019/044489 WO2020028558A1 (en) | 2018-07-31 | 2019-07-31 | Bismuth-thiol compositions and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021001272A true MX2021001272A (es) | 2021-07-15 |
Family
ID=69231251
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021001272A MX2021001272A (es) | 2018-07-31 | 2019-07-31 | Composiciones de bismuto-tiol y metodos de uso. |
| MX2023013577A MX2023013577A (es) | 2018-07-31 | 2021-01-29 | Composiciones de bismuto-tiol y metodos de uso. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023013577A MX2023013577A (es) | 2018-07-31 | 2021-01-29 | Composiciones de bismuto-tiol y metodos de uso. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11464749B2 (https=) |
| EP (1) | EP3829307A4 (https=) |
| JP (1) | JP7564101B2 (https=) |
| KR (1) | KR20210084425A (https=) |
| CN (1) | CN112804878A (https=) |
| AU (1) | AU2019315509B2 (https=) |
| BR (1) | BR112021001731A2 (https=) |
| CA (1) | CA3107760A1 (https=) |
| IL (1) | IL280414B2 (https=) |
| MX (2) | MX2021001272A (https=) |
| SG (1) | SG11202100823RA (https=) |
| WO (1) | WO2020028558A1 (https=) |
| ZA (1) | ZA202100780B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019312592B2 (en) | 2018-07-31 | 2025-06-26 | Microbion Corporation | Bismuth-thiol compositions and methods for treating wounds |
| WO2020028558A1 (en) | 2018-07-31 | 2020-02-06 | Microbion Corporation | Bismuth-thiol compositions and methods of use |
| WO2021195236A1 (en) * | 2020-03-24 | 2021-09-30 | Microbion Corporation | Bismuth thiol compounds and compositions and methods of treating microbial co-infections |
| WO2022159881A1 (en) * | 2021-01-25 | 2022-07-28 | Microbion Corporation | Amorphous form of bismuth-1,2-ethanedithiol and methods of making |
| US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
| WO2023063827A1 (en) * | 2021-10-15 | 2023-04-20 | Omnicin Therapeutics B.V. | Synergistic composition against pseudomonas aeruginosa |
| CA3248355A1 (en) * | 2022-01-10 | 2023-07-13 | Microbion Corporation | METHODS OF TREATMENT FOR NON-TUBERCULOUS MYCOBACTERIAL DISEASES |
Family Cites Families (91)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2809971A (en) | 1955-11-22 | 1957-10-15 | Olin Mathieson | Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same |
| USRE29409E (en) | 1965-03-15 | 1977-09-20 | Ventron Corporation | Phenoxarsine compounds incorporated into resins with phenols |
| US3452034A (en) | 1967-03-09 | 1969-06-24 | American Cyanamid Co | Substituted 2-(1,3,4-thiadiazol-2-yl)-4(5)-nitroimidazoles |
| ATE4908T1 (de) | 1980-08-15 | 1983-10-15 | Scott Bader Company Limited | Anstrichzusammensetzungen. |
| US4596724A (en) | 1984-05-15 | 1986-06-24 | Marine Shield Corp. | Anti-fouling coating composition, process for applying same and coating thereby obtained |
| US4788302A (en) | 1985-06-14 | 1988-11-29 | Duke University | Anti-fouling compound and method of use |
| JPH0653735B2 (ja) | 1987-08-03 | 1994-07-20 | 明治製菓株式会社 | Ｎ−アルキルベンゼンスルホニルカルバモイル−５−クロロイソチアゾ−ル誘導体および殺微生物剤 |
| ATE124864T1 (de) | 1989-03-10 | 1995-07-15 | Yamanouchi Pharma Co Ltd | Die wirkstoffabgabe steuerndes überzugsmaterial für lang wirksame formulierungen. |
| US5229124A (en) | 1990-04-02 | 1993-07-20 | Morton International, Inc. | Microbicides immobilized in water soluble thermoplastic resins and aqueous dispersions of microbicides prepared therefrom |
| US5194248A (en) | 1990-06-21 | 1993-03-16 | Trustees Of Boston University | Compositions comprising vitamin D analog precursors and the use thereof |
| JPH04325569A (ja) | 1991-04-24 | 1992-11-13 | Ishihara Sangyo Kaisha Ltd | 防汚塗料組成物 |
| US6488912B1 (en) | 1992-07-30 | 2002-12-03 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Treatment of dentoalveolar infections with taurolidine and/or taurultam |
| US5334389A (en) | 1992-10-15 | 1994-08-02 | Duke University | Antifouling coating and method for using same |
| US5384176A (en) | 1992-12-11 | 1995-01-24 | Zimmerman; Richard C. | Phenolic acid sulfate esters for prevention of marine biofouling |
| US6086921A (en) | 1995-04-25 | 2000-07-11 | Wintrop-University Hospital | Metal/thiol biocides |
| US5928671A (en) | 1995-04-25 | 1999-07-27 | Winthrop University Hospital | Method and composition for inhibiting bacteria |
| US6558686B1 (en) | 1995-11-08 | 2003-05-06 | Baylor College Of Medicine | Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor |
| US6071528A (en) | 1997-02-19 | 2000-06-06 | Ultradent Products, Inc. | Adhesive antimicrobial and/or reparative dentin stimulating dental compositions and methods for forming and using such compositions |
| US6017936A (en) | 1997-03-14 | 2000-01-25 | Arch Chemicals, Inc. | Method for producing particles of pyrithione salts and particles so produced |
| US5999828A (en) | 1997-03-19 | 1999-12-07 | Qualcomm Incorporated | Multi-user wireless telephone having dual echo cancellers |
| US6455031B1 (en) | 1997-06-18 | 2002-09-24 | David G Davies | Methods and compositions for controlling biofilm development |
| AU2003204105B2 (en) | 1997-10-28 | 2005-11-17 | Winthrop-University Hospital | Metal/Thiol Biocides |
| JPH11158328A (ja) | 1997-11-27 | 1999-06-15 | Fujikura Rubber Ltd | 抗菌性ゴム部品 |
| AU2656799A (en) | 1998-02-04 | 1999-08-23 | Winthrop-University Hospital | Metal-thiols as imminomodulating agents |
| GB9802355D0 (en) | 1998-02-04 | 1998-04-01 | Ciba Geigy Ag | Organic compounds |
| US6465015B1 (en) | 1998-02-24 | 2002-10-15 | Arch Chemicals, Inc. | Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles |
| TWI245763B (en) | 1998-04-02 | 2005-12-21 | Janssen Pharmaceutica Nv | Biocidal benzylbiphenyl derivatives |
| AU6261499A (en) | 1998-09-23 | 2000-04-10 | Phycogen, Inc. | Antifouling agents |
| US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
| US6261539B1 (en) | 1998-12-10 | 2001-07-17 | Akwete Adjei | Medicinal aerosol formulation |
| US6682724B2 (en) | 1999-02-23 | 2004-01-27 | Arch Chemcials, Inc. | Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles |
| JP2000336080A (ja) | 1999-05-28 | 2000-12-05 | Nippon Bayer Agrochem Co Ltd | イソチアゾールカルボキサミド類 |
| WO2001064644A1 (en) | 2000-03-01 | 2001-09-07 | Nihon Bayer Agrochem K.K. | Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides |
| WO2002032387A1 (es) | 2000-10-16 | 2002-04-25 | Biocosmetics, S.L. | Empleo del aceite de oliva en la elaboración de un producto para higiene oral para la eliminación o reducción de la placa bacteriana y/o bacterias presentes en la cavidad bucal |
| US6726898B2 (en) | 2000-11-17 | 2004-04-27 | Gary R. Jernberg | Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease |
| US6630172B2 (en) | 2001-01-22 | 2003-10-07 | Kareem I. Batarseh | Microbicidal composition containing potassium sodium tartrate |
| US6582719B2 (en) | 2001-02-02 | 2003-06-24 | The Trustees Of Columbia University In The City Of New York | Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms |
| PT1997478E (pt) | 2001-02-15 | 2013-12-10 | Access Pharma Inc | Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas |
| US6555599B2 (en) | 2001-03-26 | 2003-04-29 | Milliken & Company | Antimicrobial vulcanized EPDM rubber articles |
| US6448306B1 (en) | 2001-03-23 | 2002-09-10 | Milliken & Company | Antimicrobial articles made from nitrile or natural rubber |
| EP1381644A4 (en) | 2001-03-23 | 2005-11-02 | Milliken & Co | ANTIMICROBIAL RUBBER COMPOSITIONS |
| US6730324B2 (en) | 2001-04-20 | 2004-05-04 | The University Of British Columbia | Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| EP1531837A4 (en) | 2001-06-07 | 2006-11-15 | Chiou Consulting Inc | COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF APHTEOUS ULCERS AND LESIONS DUE TO HERPES |
| US6638993B2 (en) | 2001-12-12 | 2003-10-28 | Milliken & Company | Colored antimicrobial vulcanized rubber articles |
| US6579513B1 (en) | 2002-01-03 | 2003-06-17 | Playtex Products, Inc. | Hygiene mouthspray composition |
| US7438925B2 (en) | 2002-08-26 | 2008-10-21 | Biovention Holdings Ltd. | Drug eluting coatings for medical implants |
| JP4357166B2 (ja) | 2002-10-21 | 2009-11-04 | 日揮触媒化成株式会社 | 抗菌・防黴・防藻性組成物 |
| US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
| US6861049B2 (en) | 2002-11-12 | 2005-03-01 | Douglas B. Harwood | Aqueous slurries useful for cleaning the tongue and throat |
| US6848871B1 (en) | 2002-12-19 | 2005-02-01 | Cottrell, Inc. | Strap tie-down system |
| JP2004307483A (ja) | 2003-04-07 | 2004-11-04 | Rohm & Haas Co | 殺微生物組成物 |
| US7060739B2 (en) | 2003-04-25 | 2006-06-13 | Milliken & Company | Antimicrobial fluoroelastomer rubber articles and compositions |
| US6943205B2 (en) | 2003-04-25 | 2005-09-13 | Milliken & Company | Antimicrobial articles and compositions made from styrene butadiene rubber |
| US6852782B2 (en) | 2003-04-25 | 2005-02-08 | Milliken & Company | Antimicrobial articles and compositions made from non-silicone vulcanized rubber |
| US6875453B2 (en) | 2003-07-18 | 2005-04-05 | Manuel Viamonte, Jr. | Non-toxic disinfectant containing a isopropyl alcohol and sesame oil composition with lemon oil and menthol |
| US7381751B2 (en) | 2003-08-26 | 2008-06-03 | Shantha Sarangapani | Antimicrobial composition for medical articles |
| KR101297061B1 (ko) | 2004-07-02 | 2013-08-19 | 베링거 인겔하임 인터내셔날 게엠베하 | 추진제로서 ｔｇ ２２７ ｅａ 또는 ｔｇ １３４ ａ를함유하는 에어로졸 현탁액 제형 |
| ATE503465T1 (de) | 2004-10-25 | 2011-04-15 | Celonova Biosciences Germany Gmbh | Beladbare polyphosphazenhaltige teilchen für therapeutische und/oder diagnostische anwendungen sowie herstellungs- und verwendungsverfahren dafür |
| US7419681B2 (en) | 2004-12-02 | 2008-09-02 | Bioretec, Ltd. | Method to enhance drug release from a drug-releasing material |
| US20090191254A1 (en) | 2004-12-06 | 2009-07-30 | The Govt. Of The U.S.A., Centers For Disease Control And Prevention | Inhibition of biofilm formation using bacteriophage |
| US20060205838A1 (en) | 2005-03-10 | 2006-09-14 | Velamakanni Bhaskar V | Hardenable antimicrobial dental compositions and methods |
| EP1888088A4 (en) | 2005-05-26 | 2012-07-04 | Chr Hansen As | BACTERIAL REGULATION IN ANIMAL CONTAINMENT SYSTEMS |
| US7507281B2 (en) | 2005-09-02 | 2009-03-24 | Microban Products Company | Antimicrobial cementitious composition, method and article |
| BRPI0617663A2 (pt) | 2005-10-21 | 2011-08-02 | Panacea Biotec Ltd | composições aperfeiçoadas para terapia de cáncer |
| US8268395B2 (en) | 2005-12-05 | 2012-09-18 | E. I. Du Pont De Nemours And Company | Method for providing resistance to biofouling in a porous support |
| JP4568232B2 (ja) | 2006-01-06 | 2010-10-27 | 秀和 西松 | 人工骨頭保持具 |
| JP2007332040A (ja) | 2006-06-12 | 2007-12-27 | Shinshu Univ | カーボンナノチューブを含む抗菌剤とそれを用いた材料及び製剤 |
| GB0618697D0 (en) | 2006-09-22 | 2006-11-01 | Syntopix Ltd | Formulations |
| US20110008402A1 (en) | 2006-10-13 | 2011-01-13 | Kane Biotech Inc. | Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof |
| EP2104558A2 (en) | 2006-12-12 | 2009-09-30 | Sol-Gel Technologies Ltd. | Formation of nanometric core-shell particles having a metal oxide shell |
| EP2117611B1 (en) | 2007-01-24 | 2014-07-30 | Cook Medical Technologies LLC | Biofilm-inhibiting medical products |
| US8343536B2 (en) | 2007-01-25 | 2013-01-01 | Cook Biotech Incorporated | Biofilm-inhibiting medical products |
| US8282949B2 (en) | 2007-05-18 | 2012-10-09 | Sciessent Llc | Bioactive acid agrichemical compositions and use thereof |
| WO2008150375A1 (en) | 2007-06-01 | 2008-12-11 | Arrow International, Inc. | Combined fibrinolytic and antimicrobial catheter and uses thereof |
| WO2009014549A1 (en) | 2007-07-25 | 2009-01-29 | Celonova Biosciences, Inc. | Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| EP2237788A4 (en) | 2007-12-27 | 2013-06-05 | Aires Pharmaceuticals Inc | COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF |
| US20090197003A1 (en) | 2008-02-01 | 2009-08-06 | Thomas Van Zandt | Anti-fouling coatings, Compounds, and methods |
| WO2009102787A2 (en) | 2008-02-12 | 2009-08-20 | Boston Scientific Scimed, Inc. | Medical implants with polysaccharide drug eluting coatings |
| US20110092589A1 (en) | 2008-03-10 | 2011-04-21 | The Charlotte-Mecklenburg Hospotal Authority | Treatment of Inflammatory Conditions and Diseases with Metal-Thiols |
| EP2393491B1 (en) | 2009-02-03 | 2020-04-22 | Microbion Corporation | Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications |
| US9408393B2 (en) | 2010-02-03 | 2016-08-09 | Microbion Corporation | Bismuth-thiols as antiseptics for agricultural, industrial and other uses |
| US20200138033A1 (en) * | 2009-02-03 | 2020-05-07 | Microbion Corporation | Bismuth-thiols as antiseptics for agricultural, industrial and other uses |
| US9028878B2 (en) | 2009-02-03 | 2015-05-12 | Microbion Corporation | Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
| KR101966867B1 (ko) | 2010-02-03 | 2019-04-08 | 마이크로비온 코포레이션 | 세균 균막의 치료 및 다른 용도를 포함하는, 생의학적 용도를 위한 방부제로서 비스무트-티올 |
| JP2013518895A (ja) | 2010-02-03 | 2013-05-23 | マイクロビオン コーポレーション | 細菌バイオフィルムの処置および他の使用をはじめとする、生体医学的使用のための消毒薬としてのビスマス−チオール |
| JP6336246B2 (ja) | 2013-03-13 | 2018-06-06 | 大同化成工業株式会社 | ナノ粒子化製剤及びその製造方法 |
| US20140287039A1 (en) | 2013-03-15 | 2014-09-25 | Iceutica Inc. | Abiraterone Acetate Formulation |
| EP3179982B1 (en) | 2014-07-28 | 2023-07-19 | Sun Pharma Advanced Research Company Ltd | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug |
| JP6856620B2 (ja) | 2015-07-27 | 2021-04-07 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ | 薬剤搭載ナノ樹脂粒子 |
| WO2020028558A1 (en) | 2018-07-31 | 2020-02-06 | Microbion Corporation | Bismuth-thiol compositions and methods of use |
| AU2019312592B2 (en) | 2018-07-31 | 2025-06-26 | Microbion Corporation | Bismuth-thiol compositions and methods for treating wounds |
-
2019
- 2019-07-31 WO PCT/US2019/044489 patent/WO2020028558A1/en not_active Ceased
- 2019-07-31 US US16/528,145 patent/US11464749B2/en active Active
- 2019-07-31 KR KR1020217005824A patent/KR20210084425A/ko active Pending
- 2019-07-31 CA CA3107760A patent/CA3107760A1/en active Pending
- 2019-07-31 EP EP19843994.5A patent/EP3829307A4/en active Pending
- 2019-07-31 IL IL280414A patent/IL280414B2/en unknown
- 2019-07-31 MX MX2021001272A patent/MX2021001272A/es unknown
- 2019-07-31 JP JP2021529237A patent/JP7564101B2/ja active Active
- 2019-07-31 AU AU2019315509A patent/AU2019315509B2/en active Active
- 2019-07-31 BR BR112021001731-3A patent/BR112021001731A2/pt unknown
- 2019-07-31 SG SG11202100823RA patent/SG11202100823RA/en unknown
- 2019-07-31 CN CN201980064742.1A patent/CN112804878A/zh active Pending
-
2021
- 2021-01-29 MX MX2023013577A patent/MX2023013577A/es unknown
- 2021-02-04 ZA ZA2021/00780A patent/ZA202100780B/en unknown
-
2022
- 2022-10-03 US US17/959,032 patent/US12186283B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20230165808A1 (en) | 2023-06-01 |
| IL280414B2 (en) | 2025-02-01 |
| JP7564101B2 (ja) | 2024-10-08 |
| US11464749B2 (en) | 2022-10-11 |
| AU2019315509A1 (en) | 2021-02-18 |
| MX2023013577A (es) | 2023-11-30 |
| ZA202100780B (en) | 2023-07-26 |
| EP3829307A4 (en) | 2022-08-03 |
| JP2021533193A (ja) | 2021-12-02 |
| EP3829307A1 (en) | 2021-06-09 |
| IL280414B1 (en) | 2024-10-01 |
| KR20210084425A (ko) | 2021-07-07 |
| WO2020028558A1 (en) | 2020-02-06 |
| BR112021001731A2 (pt) | 2021-04-27 |
| SG11202100823RA (en) | 2021-02-25 |
| US20200046650A1 (en) | 2020-02-13 |
| CN112804878A (zh) | 2021-05-14 |
| CA3107760A1 (en) | 2020-02-06 |
| IL280414A (en) | 2021-03-25 |
| AU2019315509B2 (en) | 2025-06-26 |
| US12186283B2 (en) | 2025-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023013577A (es) | Composiciones de bismuto-tiol y metodos de uso. | |
| MY198425A (en) | Glp-1 Compositions and uses Thereof | |
| JOP20230272A1 (ar) | مركبات تثبيط rip1 وطرق لتحضير واستخدامها | |
| MX2020009956A (es) | Compuestos para el tratamiento de enfermedad de hungtinton. | |
| MX2022013612A (es) | Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas. | |
| MX2021001091A (es) | Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington. | |
| PH12020500257A1 (en) | Quinoline derivatives for treating infections with helminths | |
| SG10201908839QA (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| MX389802B (es) | Composiciones enriquecidas estereoquimicamente para administracion de acidos nucleicos. | |
| MX2017012545A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| PH12021550705A1 (en) | Stable semaglutide compositions and uses thereof | |
| MX2021003773A (es) | Composiciones farmacéuticas y métodos relacionados con los agentes terapéuticos óticos. | |
| BR112017000246A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| NO20180002A1 (en) | Aminobenzisoxazole compounds as agonists of A7-nicotinic acetylcholine receptors | |
| MX2017012535A (es) | Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| NZ757526A (en) | Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction | |
| EA201890075A1 (ru) | Инъецируемые фармацевтические композиции лефамулина | |
| SA520420261B1 (ar) | تركيبات إرنوماب واستخداماتها | |
| MX2017014080A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| PH12020500204A1 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic disease | |
| MX2020009496A (es) | Metodo para tratar asma o enfermedad alergica. | |
| ZA202001568B (en) | Methods and compositions for treating chronic lung diseases | |
| MX2020012609A (es) | Inhibidor del hif-1?, metodo de preparacion del mismo, y composicion farmaceutica para prevenir o tratar la enfermedad ocular asociada a la angiogenesis, que contiene el mismo como ingrediente activo. | |
| BR112020024261B8 (pt) | Composto de fórmula (ia) e composição farmacêutica |